Metraipolis › archive › dc_964792eda083

Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42295856
DOI
10.34067/kid.0000001262
License (as archived)
solo-consultazione
Archived
2026-10-31T10:56:26.028Z
SHA-256 of the archived text
4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501
Stable URL of this page
https://metraipolis.com/documento/dc_964792eda083

How to cite

Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856 — Europe PMC (en), https://europepmc.org/article/MED/42295856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_964792eda083 (Metraipolis archive dc_964792eda083, sha256 4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501)
BibTeX
@misc{dc964792eda083,
  title = {Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42295856},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_964792eda083; sha256 4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42295856. Agents can read the archived copy with the MCP tool read_document.